We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
HYDRAPRES hydralazine hydrochloride 20mg powder for injectable solution ampoules (Spain)
Section 19A approved medicine
HYDRAPRES hydralazine hydrochloride 20mg powder for injectable solution ampoules (Spain)
Section 19A approval holder
Boucher & Muir Pty Ltd T/A Advanz Pharma ABN 58 000 140 474
Phone
1800 627 680
Approved until
Status
Current
Medicines in short supply/unavailable
APRESOLINE hydralazine hydrochloride 20mg powder for injection ampoule - ARTG 43290
Indication(s)
Hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia)
Additional information
This approval commences on 01 August 2025.
Images
